Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization

1. Evaluate the efficacy and safety of Qidan Xiaohe granules in patients after coronary revascularization surgery; 2. Develop a traditional Chinese medicine rehabilitation treatment plan and evaluation system for the use of Qidan Xiaohe granules after coronary revascularization surgery; 3. Demonstrate the advantages of traditional Chinese medicine rehabilitation treatment in the postoperative management of coronary revascularization surgery and provide high-level evidence-based medical evidence for the development of traditional Chinese medicine rehabilitation treatment plans.

Participants needed: 164
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Liu QiangUpdated: Jun 1, 2026
Eligibility criteria

Age: 18-80 years old; [+4]

Severe hepatic and/or renal insufficiency [+12]

Status: Not yet recruiting

Establishment of Disease Characteristics and a Chinese Medicine Prognosis Risk Model Based on a Large-Scale Database After Coronary Revascularization

This study aims to develop a risk prediction model for patients who have undergone coronary revascularization (such as stent placement or bypass surgery). After these procedures, some patients still experience heart-related problems like chest pain, heart attack, or rehospitalization. This study will enroll 600 patients from multiple hospitals in China and follow them for 12 months. At enrollment and at 12, 24, 36, and 48 weeks after surgery, researchers will collect clinical information (including traditional Chinese medicine symptoms, blood tests, heart imaging) and biological samples (blood and tongue coating). Using artificial intelligence, the study will build a predictive model that combines Western medical data with traditional Chinese medicine characteristics. The goal is to better identify patients at higher risk of future heart events, so that personalized prevention and management can be provided. The study does not involve any experimental treatment or intervention - it is purely observational.

Participants needed: 600
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Liu QiangUpdated: May 29, 2026Duration: 12 Months
Eligibility criteria

Diagnosis of coronary artery disease with prior coronary revascularization (PCI... [+2]

Malignant arrhythmias, severe heart failure, myocardial disease, or structural h... [+4]

Status: Not yet recruiting

Baduanjin Intervention in Clinical Studies After Coronary Revascularization Surgery

1. To evaluate the efficacy and safety of the Baduanjin exercise programme in patients following coronary revascularisation surgery; 2. To develop a traditional Chinese medicine (TCM) rehabilitation protocol and evaluation system for patients following coronary revascularisation surgery; 3. To clarify the advantages of TCM rehabilitation in the post-operative management of coronary revascularisation surgery and to provide high-level evidence-based medical evidence for TCM rehabilitation protocols.

Participants needed: 310
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Liu QiangUpdated: May 27, 2026
Eligibility criteria

Participants who meet the diagnostic criteria for coronary heart disease [+4]

Subjects with severe hepatic or renal impairment [+12]